EQUITY-METHOD INVESTMENTS

The Company’s two equity-method investments totaled $17.0 million and $14.6 million as of December 31, 2019 and 2018, respectively, and are included in other noncurrent assets in the accompanying consolidated balance sheets. The Company’s related proportionate share of earnings is recorded in equity in earnings of joint ventures in the accompanying consolidated statements of comprehensive income (loss). For the years ended December 31, 2019, 2018 and 2017, the Company’s proportionate share of earnings in its equity-method investees was $2.8 million, $1.0 million and $2.2 million, respectively.

Legacy Health Systems — The Company’s 50% ownership interest in this limited liability company, which provides infusion pharmacy services, expands the Company’s presence in the Portland, Oregon market. In 2005, Option Care’s initial cash investment in this joint venture was $1.3 million. The Company received a capital distribution from this investment of $0.5 million, $2.0 million and $1.3 million for the years ended December 31, 2019, 2018 and 2017, respectively. The following presents condensed financial information as of December 31, 2019 and December 31, 2018 and for the years ended December 31, 2019, 2018 and 2017 (in thousands):



Consolidated statements of comprehensive income (loss) data:
	Year Ended December 31,
	2019		2018		2017
Net revenue	$	21,037	$	21,309	$	23,295
Cost of revenue	14,792		15,042		17,069
Gross profit	6,245		6,267		6,226
Net income	1,986		1,772		3,278
Equity in net income	993		886		1,639



Consolidated balance sheet data:
	As of December 31,
	2019		2018
Current assets	$	7,643	$	5,666
Noncurrent assets	3,846		3,403
Current liabilities	903		119
Noncurrent liabilities	659		8

Vanderbilt Health Services — The Company’s 50% ownership interest in this limited liability company, which provides infusion pharmacy services, expands the Company’s presence in the Nashville, Tennessee market. In 2009, Option Care contributed both cash and certain operating assets into the joint venture for a total initial investment of $1.1 million. The following presents condensed financial information as of December 31, 2019 and 2018 and for the years ended December 31, 2019, 2018 and 2017, (in thousands):



Consolidated statements of comprehensive income (loss) data:
	Year Ended December 31,
	2019		2018		2017
Net revenue	$	38,744	$	31,517	$	27,805
Cost of revenue	29,952		24,433		20,665
Gross profit	8,792		7,084		7,140
Net income	3,694		268		1,094
Equity in net income	1,847		134		547



Consolidated balance sheet data:
	As of December 31,
	2019		2018
Current assets	$	11,111	$	6,517
Noncurrent assets	2,033		1,008
Current liabilities	1,228		192
Noncurrent liabilities	956		68